Compare Franklin Resources, Inc. (BEN) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Franklin Resources, Inc. vs GeneDx Holdings Corp — how do they compare? Franklin Resources, Inc. trades at $33.37 (market cap $16.95B), while GeneDx Holdings Corp trades at $81.98 (market cap $2.44B). The key difference: Franklin Resources, Inc. is far larger — about 6.9× GeneDx Holdings Corp's market cap, and Franklin Resources, Inc. pays a 3.96% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| BEN | WGS | |
|---|---|---|
Market Cap | $16.95B | $2.44B |
Sector | Financials | Technology |
52-Week High | $35.77 | $167.51 |
52-Week Low | $21.18 | $34.51 |
Enterprise Value | $29.90B | $2.48B |
Dividend Yield | 3.96% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Franklin Resources, Inc.
Franklin Resources provides investment services for individual and institutional investors. At the end of August 2022, Franklin had $1.388 trillion in managed assets, composed primarily of equity (32%), fixed-income (38%), multi-asset/balanced (10%) funds, alternatives (16%), and money market funds (4%). Distribution tends to be weighted more toward retail investors (49% of AUM) investors, as opposed to institutional (49%) and high-net-worth (2%) clients. Franklin is also one of the more global firms of the U.S.-based asset managers with more than 35% of its AUM invested in global/international strategies and 25% of managed assets sourced from clients domiciled outside the United States.
Read more on BEN →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
